Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

0NIQ

Sartorius (0NIQ)

Sartorius Ag
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:0NIQ
FechaHoraFuenteTítuloSímboloCompañía
26/01/202300:00PR Newswire (US)Sartorius with clear double-digit growth in fiscal 2022LSE:0NIQSartorius Ag
11/11/202204:30PR Newswire (US)Sartorius successfully places Schuldschein loans with a volume of 650 million eurosLSE:0NIQSartorius Ag
19/10/202200:00PR Newswire (US)Sartorius with continued growth in a challenging environmentLSE:0NIQSartorius Ag
08/08/202211:30PR Newswire (US)Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutionsLSE:0NIQSartorius Ag
21/07/202200:00PR Newswire (US)Sartorius remains on growth trackLSE:0NIQSartorius Ag
19/05/202207:00PR Newswire (US)Sartorius continues global capacity expansion with opening of extended plant in TunisiaLSE:0NIQSartorius Ag
25/03/202209:30PR Newswire (US)Resolutions of the Annual General Shareholders' Meeting of Sartorius AGLSE:0NIQSartorius Ag
25/03/202206:30PR Newswire (US)Sartorius Annual General Shareholders' Meeting: Focus on innovation, growth and sustainabilityLSE:0NIQSartorius Ag
17/02/202201:30PR Newswire (US)Sartorius presents annual report for 2021LSE:0NIQSartorius Ag
10/02/202208:15PR Newswire (US)The Supervisory Board of Sartorius AG proposes dividend of 1.26 euros per preference shareLSE:0NIQSartorius Ag
08/02/202201:30PR Newswire (US)Sartorius completes acquisition of Novasep's chromatography divisionLSE:0NIQSartorius Ag
27/01/202200:00PR Newswire (US)Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitabilityLSE:0NIQSartorius Ag
16/12/202106:15PR Newswire (US)Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab SolutionsLSE:0NIQSartorius Ag
26/11/202109:30PR Newswire (US)Sartorius grows operations in France and is investing 100 million euros by 2025LSE:0NIQSartorius Ag
25/11/202104:30PR Newswire (US)Sartorius significantly expands activities in South KoreaLSE:0NIQSartorius Ag
20/10/202100:00PR Newswire (US)Sartorius grows dynamically and profitably - Substantial double-digit increases in sales and earningsLSE:0NIQSartorius Ag
13/10/202100:30PR Newswire (US)Change in Composition of Sartorius Joint HeirshipLSE:0NIQSartorius Ag
27/09/202104:00PR Newswire (US)Sartorius to expand Business Operations in North AmericaLSE:0NIQSartorius Ag
16/09/202103:30PR Newswire (US)Sartorius to Open New Application and Service Hub in ShanghaiLSE:0NIQSartorius Ag
04/09/202102:00PR Newswire (US)Sartorius To Join The DAX Blue Chip IndexLSE:0NIQSartorius Ag
29/07/202103:00PR Newswire (US)Sartorius acquires cell culture specialist Xell AGLSE:0NIQSartorius Ag
21/07/202100:00PR Newswire (US)Sartorius continues on its fast growth trajectory - significant double-digit increases in sales and earningsLSE:0NIQSartorius Ag
05/07/202112:55PR Newswire (US)Sartorius provides preliminary first-half financial key figures and raises forecast for 2021LSE:0NIQSartorius Ag
02/07/202107:00PR Newswire (US)Sartorius strengthens product portfolio for cell and gene therapies by acquiring a majority stake in CellGenixLSE:0NIQSartorius Ag
28/05/202106:20PR Newswire (US)Sartorius expands production capacities for products for the purification of vaccines and therapeutics in SloveniaLSE:0NIQSartorius Ag
21/04/202100:00PR Newswire (US)Sartorius with first-quarter uptick in sales and earningsLSE:0NIQSartorius Ag
26/03/202110:47PR Newswire (US)Resolutions of the Annual Shareholders' Meeting of Sartorius AGLSE:0NIQSartorius Ag
06/03/202103:00PR Newswire (US)Sartorius is a corporate partner of the Healthcare Businesswomen's AssociationLSE:0NIQSartorius Ag
18/02/202106:00PR Newswire (US)Sartorius looks back on a very successful 2020 and expects further strong growthLSE:0NIQSartorius Ag
11/02/202112:58PR Newswire (US)Resolutions of the Supervisory Board of Sartorius AGLSE:0NIQSartorius Ag
 Showing the most relevant articles for your search:LSE:0NIQ